Skip to content
healthcare.dev

AZACITIDINE

NDC 83774-102, azacitidine for, injection, powder, lyophilized, for solution, from Pilnova Pharma Inc.

Product NDC
83774-102
Status
Listed
Labeler
Pilnova Pharma Inc
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207518
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83774-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZACITIDINE100 mg/1

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
83774-102-01837740102011 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (83774-102-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0095c67b-42f3-47e6-92db-f77843727bca

Use it

Look up 83774-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83774-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83774-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.